Trial is under way for SynapDx's early autism test

05/10/2013 | American City Business Journals

SynapDx is conducting a clinical trial to test its blood-based assay in diagnosing autism in children 18 months or older. The trial, launched last month, involves 660 children at 20 clinical sites. The average age at which autism is detected is 4.5 years, and earlier detection would allow earlier treatment.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC